Sarrah Strimel Bentley and her boyfriend, James, were walking their dog at sunset when she felt an itch under her armpit. She ...

The latest data from studies across Bayer's oncology and women's health portfolios will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in ...

Regular use of a common pain reliever weakens key immune system functions, potentially increasing infection risk and slowing ...

SENTI-202 a first-in-class, off-the-shelf investigational cell therapy that uses engineered natural killer cells to target CD33 or FLT3 but not EMCN (CAR-NK), helping it more precisely attack certain ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...

The scientists also state that four patients reported grade 3 or higher febrile neutropenia and decreased ... some characteristics of AML and other blood cancers make them more challenging to ...

Discover how stress increases your risk of painful urinary tract infections and learn effective prevention strategies that ...

SENTI-202, an off-the-shelf, logic-gated, CAR natural killer cell therapy drove complete remission of pretreated blood cancers in a first-in-human trial, according to results presented by Stephen ...

Blood levels of hemoglobin ... acute side effects of chemotherapy and radiation therapy, including fever, neutropenia, mucositis, and pain. These toxic effects are common with rhabdomyosarcoma ...